Skip to main content
MedPathMedPath Home
Clinical Trials/JPRN-UMIN000003090
JPRN-UMIN000003090
Completed
Phase 1

A phase I trial of stereotactic body radiotherapy for limited hepatocellular carcinoma - HCC-SBRT P1 Study

Division of Radiation Oncology and division of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Tokyo, Japan0 sites12 target enrollmentJanuary 25, 2010
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHepatocellular carcinoma

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Hepatocellular carcinoma
Sponsor
Division of Radiation Oncology and division of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Tokyo, Japan
Enrollment
12
Status
Completed
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 25, 2010
End Date
March 14, 2019
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Division of Radiation Oncology and division of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Tokyo, Japan

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • •1\) Uncontrolled ascites 2\) Gastric/esophageal varix which needs preventive treatment 3\) Tumor thrumbus in main trunk of portal vein or IVC 4\) Case with critical complication 5\) Simultaneous cancer 6\) In pregnancy or with expectation of pregnancy

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Phase 1
Phase I study of postoperative stereotactic body radiotherapy for prostate cancer
JPRN-jRCT1030220062Yamashita Hideomi36
Active, not recruiting
Phase 1
Phase I trial of stereotactic body radiotherapy with concurrent pembrolizumab in metastatic urothelial cancer.Metastatic urothelial cancerTherapeutic area: Diseases [C] - Cancer [C04]
EUCTR2016-001263-37-BEZ Gent20
Completed
Phase 1
A phase I study of stereotactic body radiotherapy with real-time tumor tracking using CyberKnife and Monte Carlo algorithm for lung tumors.lung tumor
JPRN-UMIN000005061Department of Radiology, Nagoya City University Graduate School of Medical Sciences35
Completed
Not Applicable
Phase II trial of stereotactic body radiotherapy for non-spine bone metastases.non-spine bone metastases
JPRN-UMIN000033132Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital35
Completed
Phase 2
Phase II trial of stereotactic body radiotherapy with a hydrogel spacer for prostate cancerProstate cancer
JPRN-UMIN000026213The University of Tokyo Hospital42